Transaction Type: Direct Capital Investment
Industry: Biotech Company
The Company was involved in the application of technical life science advances to develop commercial products. We followed the company's development to initial public offering and purchased stock in the open market, as we felt the company showed potential.

After becoming investors in the business, we built a strong relationship with the management team, learning about their short and long-term strategic plans.

When the company decided to raise additional capital, it approached us to act as a lead investor, given the breadth of our relationship.

Upon being approached, we carried out additional original research on the company, industry and technology. Following successful due diligence, we made a sizeable direct investment into the company and have remained long-term shareholders.

Since then, the company has evolved from being listed on the Bulletin Board index to being listed on the Nasdaq.